What’s in a name? Moderna’s “vaccine” vs. “therapy” dilemma
Is it the Department of Defense or the Department of War? The Gulf of Mexico or the Gulf of America? A vaccine—or an “individualized neoantigen treatment”? That’s the Trump-era vocabulary paradox facing Moderna, the covid-19 shot maker whose plans for next-generation mRNA vaccines against flus and emerging pathogens have been dashed by vaccine skeptics in…
Source Articles
MIT Technology Review (United States) | Apr 10, 2026
Your votes count
No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.
💡 How This Works
- • Add Statements: Post claims or questions (10-500 characters)
- • Vote: Agree, Disagree, or Unsure on each statement
- • Respond: Add detailed pro/con responses with evidence
- • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement
Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.
Support us